These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9817980

  • 21. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L, Cheng J, Zhou M, Yao Z, Zhang Y.
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
    [Abstract] [Full Text] [Related]

  • 22. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    Chen P, Jiao L, Ren F, Wang DB.
    BMC Cancer; 2020 May 14; 20(1):423. PubMed ID: 32410650
    [Abstract] [Full Text] [Related]

  • 23. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM, De Bruijn HW, Groenier KH, Fleuren GJ, Aalders JG.
    Cancer; 1990 Apr 15; 65(8):1830-7. PubMed ID: 2317761
    [Abstract] [Full Text] [Related]

  • 24. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH, Yu M, Jeong S, Lee JH.
    Int J Clin Oncol; 2020 Jul 15; 25(7):1405-1411. PubMed ID: 32221801
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H, Devos P, Janssens J, Mortelmans L, Gerits M, Bonte J, De Roo M.
    Gynecol Obstet Invest; 1991 Jul 15; 32(1):55-8. PubMed ID: 1765320
    [Abstract] [Full Text] [Related]

  • 26. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer.
    Pectasides D, Economides N, Bourazanis J, Pozadzizou P, Gogou L, Koutsiouba P, Athanassiou A.
    Am J Clin Oncol; 1994 Aug 15; 17(4):307-12. PubMed ID: 8048392
    [Abstract] [Full Text] [Related]

  • 27. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
    Ogino I, Nakayama H, Kitamura T, Okamoto N, Inoue T.
    Int J Gynecol Cancer; 2005 Aug 15; 15(4):630-8. PubMed ID: 16014117
    [Abstract] [Full Text] [Related]

  • 28. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ.
    Gynecol Oncol; 1997 Mar 15; 64(3):418-24. PubMed ID: 9062143
    [Abstract] [Full Text] [Related]

  • 29. Squamous cell carcinoma antigen in cervical cancer.
    Borras G, Molina R, Xercavins J, Ballesta A, Iglesias X.
    Eur J Gynaecol Oncol; 1992 Mar 15; 13(5):414-8. PubMed ID: 1486921
    [Abstract] [Full Text] [Related]

  • 30. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S.
    PLoS One; 2015 Mar 15; 10(4):e0122361. PubMed ID: 25860888
    [Abstract] [Full Text] [Related]

  • 31. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.
    Pras E, Willemse PH, Canrinus AA, de Bruijn HW, Sluiter WJ, ten Hoor KA, Aalders JG, Szabo BG, de Vries EG.
    Int J Radiat Oncol Biol Phys; 2002 Jan 01; 52(1):23-32. PubMed ID: 11777619
    [Abstract] [Full Text] [Related]

  • 32. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH, Sjövall K, Nilsson BR, Eneroth PH.
    Eur J Cancer; 1992 Jan 01; 28A(10):1695-702. PubMed ID: 1389488
    [Abstract] [Full Text] [Related]

  • 33. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr 01; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

  • 34. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
    Fuith LC, Daxenbichler G.
    Gynecol Obstet Invest; 1988 Apr 01; 26(1):77-82. PubMed ID: 3169633
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
    Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM, Chiu LM.
    Eur J Gynaecol Oncol; 2002 Apr 01; 23(1):17-20. PubMed ID: 11876385
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Yang SN, Lin FJ.
    Tumour Biol; 2008 Apr 01; 29(4):255-61. PubMed ID: 18781097
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.